Teva to Buy Cephalon for $6.2 Billion

a blockbuster. Copaxone Sales Former Teva Chairman Eli Hurvitz picked up Copaxone after it had been rejected by Johnson & Johnson and Upjohn, a U.S. drugmaker later bought by Pfizer. One of the first therapies for multiple sclerosis, the 14-year-old...